Has Mary Ellen Luchetti, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,790 in general payments to Mary Ellen Luchetti, MD across 68 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Ellen Luchetti, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Ellen Luchetti, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Ellen Luchetti, MD

Dermatology · Albuquerque, NMNPI 1679565964

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,516 of the $1,790 with a category attached, or 84.7%. It is spread thinly across 22 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $493 and has fallen 74.3% since, to $127 in 2025.

$1,790in general payments, 2019–2025

Across 68 payments — averaging $26.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$263
Johnson & Johnson$225
E.r. Squibb & Sons, L.L.C.$162
Sun Pharmaceutical Industries Inc.$160
Lilly USA, LLC$139
Pfizer$136
plus $706 from 16 others

What the payments were for

Food & beverage$1,51685%
Education$27415%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	8	$263
Johnson & Johnson	5	$225
E.r. Squibb & Sons, L.L.C.	3	$162
Sun Pharmaceutical Industries Inc.	9	$160
Lilly USA, LLC	6	$139
Pfizer	5	$136
Incyte Corporation	7	$133
Arcutis Biotherapeutics, Inc.	1	$111
Galderma Laboratories, L.p.	4	$64
UCB, Inc.	3	$57
Novartis	2	$50
Merz North America, Inc.	2	$47
Journey Medical Corporation	2	$43
Regeneron Healthcare Solutions, Inc.	2	$37
LEO Pharma Inc.	2	$30
Almirall LLC	1	$25
Amgen	1	$24
Mayne Pharma Commercial LLC	1	$23
VYNE Pharmaceuticals Inc.	1	$19
Biofrontera Inc.	1	$16
Dermavant Sciences, Inc.	1	$15
Mylan Specialty L.p.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$123
Sotyktu$120

How this compares

$1,790 in reported general payments places this provider in the 55th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico →

Medicare billing

Part B allowed, 2024

$364,215

Medicare patients

1,470

Services billed

4,823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	11	$40,432
Clobetasol Propionate	116	$6,015
Fluorouracil	63	$4,910
Tacrolimus	23	$2,455
Betamethasone Dipropionate	68	$2,347
Ketoconazole	139	$2,331
Triamcinolone Acetonide	149	$1,722
Clindamycin Phosphate	42	$1,710
Calcipotriene	11	$1,558
Metronidazole	25	$1,432
Azelaic Acid	15	$1,269
Tretinoin	19	$1,123
Desonide	16	$926
Imiquimod	24	$782
Mupirocin	78	$690

Paid to pharmacies, not to this prescriber.

Other dermatology in Albuquerque

John DurkinAlbuquerque$153K
Barbara EinhornAlbuquerque$15K
Carol PurcellAlbuquerque$9K
Michaela JacobsAlbuquerque$7K
Deeptej SinghAlbuquerque$5K
Darren KemptonAlbuquerque$4K
Catherine Tchanque-FossuoAlbuquerque$3K
Shilpa ReddyAlbuquerque$3K
Monica RomeroAlbuquerque$3K
le Wen ChiuAlbuquerque$3K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →